Copyright © 2008 M. E. Bégin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. E. Freemantle, M. Vandal, J. Tremblay-Mercier, et al., “Omega-3 fatty acids, energy substrates, and brain function during aging,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 3, pp. 213–220, 2006. View at Publisher · View at Google Scholar · View at PubMed
2. E. M. Reiman, K. Chen, G. E. Alexander, et al., “Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 284–289, 2004. View at Publisher · View at Google Scholar · View at PubMed
3. J. W. Smith, A. T. Evans, B. Costall, and J. W. Smythe, “Thyroid hormones, brain function and cognition: a brief review,” Neuroscience and Biobehavioral Reviews, vol. 26, no. 1, pp. 45–60, 2002. View at Publisher · View at Google Scholar
4. P. Lemaire and L. Bherer, Psychologie du Vieillissement: Une Perspective Cognitive, de Boeck, Brussels, Belgium, 2005.
5. S. Mariotti, C. Franceschi, A. Cossarizza, and A. Pinchera, “The aging thyroid,” Endocrine Reviews, vol. 16, no. 6, pp. 686–715, 1995. View at Publisher · View at Google Scholar
6. J. D. Davis, R. A. Stern, and L. A. Flashman, “Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly,” Current Psychiatry Reports, vol. 5, no. 5, pp. 384–390, 2003. View at Publisher · View at Google Scholar
7. G. Murialdo, P. Costelli, S. Fonzi, et al., “Circadian secretion of melatonin and thyrotropin in hospitalized aged patients,” Aging, vol. 5, no. 1, pp. 39–46, 1993.
8. S. Mariotti, G. Barbesino, P. Caturegli, et al., “Complex alteration of thyroid function in healthy centenarians,” Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 5, pp. 1130–1134, 1993. View at Publisher · View at Google Scholar
9. J. Vézina, P. Cappeliez, and P. Landreville, Psychologie Gérontologique, Gaetan Morin, Montréal, Canada, 2nd edition, 2007.
10. F. I. M. Craik and T. Salthouse, The Handbook of Aging and Cognition, Lawrence Erlbaum, Mahwah, NJ, USA, 2nd edition, 2000.
11. D. H. Kausler, Learning and Memory in Normal Aging, Academic Press, San Diego, Calif, USA, 1994.
12. B. Johansson, S. H. Zarit, and S. Berg, “Changes in cognitive function of the oldest old,” Journal of Gerontology, vol. 47, pp. 75–80, 1993.
13. A. Wahlin, L. Bäckman, T. Mäntylä, A. Herlitz, M. Viitanen, and B. Winblad, “Prior knowledge and face recognition in a community-based sample of healthy, very old adults,” Journal of Gerontology, vol. 48, no. 2, pp. P54–P61, 1993.
14. M. P. J. van Boxtel, P. P. C. A. Menheere, O. Bekers, E. Hogervorst, and J. Jolles, “Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht aging study,” Psychoneuroendocrinology, vol. 29, no. 7, pp. 891–898, 2004. View at Publisher · View at Google Scholar · View at PubMed
15. P. N. Prinz, J. M. Scanlan, P. P. Vitaliano, et al., “Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men,” Journals of Gerontology. Series A, vol. 54, no. 3, pp. M111–M116, 1999.
16. S. Volpato, J. M. Guralnik, L. P. Fried, A. T. Remaley, A. R. Cappola, and L. J. Launer, “Serum thyroxine level and cognitive decline in euthyroid older women,” Neurology, vol. 58, no. 7, pp. 1055–1061, 2002.
17. Å. Wahlin, T.-B. R. Wahlin, B. J. Small, and L. Bäckman, “Influences of thyroid stimulating hormone on cognitive functioning in very old age,” Journals of Gerontology. Series B, vol. 53, no. 4, pp. P234–P239, 1998.
18. Å. Wahlin, D. Bunce, and T.-B. R. Wahlin, “Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age,” Psychoneuroendocrinology, vol. 30, no. 7, pp. 625–637, 2005. View at Publisher · View at Google Scholar · View at PubMed
19. J. Gussekloo, E. van Exel, A. J. M. de Craen, A. E. Meinders, M. Frölich, and R. G. J. Westendorp, “Thyroid status, disability and cognitive function, and survival in old age,” The Journal of the American Medical Association, vol. 292, no. 21, pp. 2591–2599, 2004. View at Publisher · View at Google Scholar · View at PubMed
20. M. H. Samuels, “Subclinical thyroid disease in the elderly,” Thyroid, vol. 8, no. 9, pp. 803–813, 1998.
21. M. I. Surks, E. Ortiz, G. H. Daniels, et al., “Subclinical thyroid disease: scientific review and guidelines for diagnosis and management,” The Journal of the American Medical Association, vol. 291, no. 2, pp. 228–238, 2004. View at Publisher · View at Google Scholar · View at PubMed
22. D. S. Cooper, “Subclinical hypothyroidism,” The New England Journal of Medicine, vol. 345, no. 4, pp. 260–265, 2001. View at Publisher · View at Google Scholar · View at PubMed
23. J. Jensovsky, E. Ruzicka, N. Spackova, and B. Hejdukova, “Changes of event related potential and cognitive processes in patients with subclinical hypothyroidism after thyroxine treatment,” Endocrine Regulations, vol. 36, no. 3, pp. 115–122, 2002.
24. F. Monzani, P. Del Guerra, N. Caraccio, et al., “Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment,” Clinical Investigator, vol. 71, no. 5, pp. 367–371, 1993.
25. M. Baldini, A. Vita, M. C. Mauri, et al., “Psychological and cognitive features in subclinical hypothyroidism,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 21, pp. 925–935, 1997.
26. T. del Ser Quijano, C. Delgado, S. Martínez Espinosa, and C. Vázquez, “Cognitive deficiency in mild hypothyroidism,” Neurologia, vol. 15, no. 5, pp. 193–198, 2000.
27. S. E. Cook, R. D. Nebes, E. M. Halligan, et al., “Memory impairment in elderly individuals with a mildly elevated serum TSH: the role of processing resources, depression and cerebrovascular disease,” Aging, Neuropsychology and Cognition, vol. 9, no. 3, pp. 175–183, 2002. View at Publisher · View at Google Scholar
28. G. Manciet, J. F. Dartigues, A. Decamps, et al., “The PAQUID survey and correlates of subclinical hypothyroidism in elderly community residents in the southwest of France,” Age and Ageing, vol. 24, no. 3, pp. 235–241, 1995. View at Publisher · View at Google Scholar
29. G. Bono, R. Fancellu, F. Blandini, G. Santoro, and M. Mauri, “Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment,” Acta Neurologica Scandinavica, vol. 110, no. 1, pp. 59–66, 2004. View at Publisher · View at Google Scholar · View at PubMed
30. E. Nyström, K. Caidahl, G. Fager, C. Wikkelsö, P.-A. Lundberg, and G. Lindstedt, “A double-blind cross-over 12-month study of L-thyroxine treatment of women with ‘subclinical’ hypothyroidism,” Clinical Endocrinology, vol. 29, no. 1, pp. 63–75, 1988. View at Publisher · View at Google Scholar
31. R. Jaeschke, G. Guyatt, H. Gerstein, et al., “Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?,” Journal of General Internal Medicine, vol. 11, no. 12, pp. 744–749, 1996. View at Publisher · View at Google Scholar
32. D. Osterweil, K. Syndulko, S. N. Cohen, et al., “Cognitive function in non-demented older adults with hypothyroidism,” Journal of the American Geriatrics Society, vol. 40, no. 4, pp. 325–335, 1992.
33. R. Luboshitzky, A. S. Oberman, N. Kaufman, N. Reichman, and E. Flatau, “Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population,” Israel Journal of Medical Sciences, vol. 32, no. 1, pp. 60–65, 1996.
34. M. J. Monzón Monguilod and I. Pérez López-Fraile, “Subclinical hypothyroidism as a cause of reversible cognitive deterioration,” Neurologia, vol. 11, no. 9, pp. 353–356, 1996.
35. J. D. Davis and R. A. Stern, “A case of apparent progressive cognitive decline in an older woman with multiple treated endocrinopathies: importance of considering endocrine status in diagnosing dementia,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 15, no. 2, p. 268, 2003.
36. C. T. Sawin, D. Chopra, F. Azizi, J. E. Mannix, and P. Bacharach, “The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly,” The Journal of the American Medical Association, vol. 242, no. 3, pp. 247–250, 1979. View at Publisher · View at Google Scholar
37. C. T. Sawin, W. P. Castelli, J. M. Hershman, P. McNamara, and P. Bacharach, “The aging thyroid. Thyroid deficiency in the Framingham study,” Archives of Internal Medicine, vol. 145, no. 8, pp. 1386–1388, 1985. View at Publisher · View at Google Scholar
38. M. P. J. Vanderpump, W. M. G. Tunbridge, J. M. French, et al., “The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey,” Clinical Endocrinology, vol. 43, no. 1, pp. 55–68, 1995. View at Publisher · View at Google Scholar
39. R. D. Lindeman, D. S. Schade, A. LaRue, et al., “Subclinical hypothyroidism in a biethnic, urban community,” Journal of the American Geriatrics Society, vol. 47, no. 6, pp. 703–709, 1999.
40. G. J. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway, “The colorado thyroid disease prevalence study,” Archives of Internal Medicine, vol. 160, no. 4, pp. 526–534, 2000. View at Publisher · View at Google Scholar
41. A. T. Dugbartey, “Neurocognitive aspects of hypothyroidism,” Archives of Internal Medicine, vol. 158, no. 13, pp. 1413–1418, 1998. View at Publisher · View at Google Scholar
42. L. A. Burmeister, M. Ganguli, H. H. Dodge, T. Toczek, S. T. Dekosky, and R. D. Nebes, “Hypothyroidism and cognition: preliminary evidence for a specific defect in memory,” Thyroid, vol. 11, no. 12, pp. 1177–1185, 2001. View at Publisher · View at Google Scholar · View at PubMed
43. C. Capet, A. Jego, P. Denis, et al., “Is cognitive change related to hypothyroidism reversible with replacement therapy?,” La Revue de Médecine Interne, vol. 21, no. 8, pp. 672–678, 2000. View at Publisher · View at Google Scholar
44. S. Crown, “Notes on an experimental study of intellectual deterioration,” British Medical Journal, vol. 2, no. 4629, pp. 684–685, 1949.
45. J. J. Haggerty, Jr., J. C. Garbutt, D. L. Evans, et al., “Subclinical hypothyroidism: a review of neuropsychiatric aspects,” International Journal of Psychiatry in Medicine, vol. 20, no. 2, pp. 193–208, 1990.
46. M. Mennemeier, R. D. Garner, and K. M. Heilman, “Memory, mood and measurement in hypothyroidism,” Journal of Clinical and Experimental Neuropsychology, vol. 15, no. 5, pp. 822–831, 1993. View at Publisher · View at Google Scholar
47. K. J. Miller, T. D. Parsons, P. C. Whybrow, et al., “Memory improvement with treatment of hypothyroidism,” International Journal of Neuroscience, vol. 116, no. 8, pp. 895–906, 2006. View at Publisher · View at Google Scholar · View at PubMed
48. C. A. Peabody, J. E. Thornton, and J. R. Tinklenberg, “Progressive dementia associated with thyroid disease,” The Journal of Clinical Psychiatry, vol. 47, no. 2, p. 100, 1986.
49. P. C. Whybrow, A. J. Prange, Jr., and C. R. Treadway, “Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement,” Archives of General Psychiatry, vol. 20, no. 1, pp. 48–63, 1969.
50. E. M. Wekking, B. C. Appelhof, E. Fliers, et al., “Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism,” European Journal of Endocrinology, vol. 153, no. 6, pp. 747–753, 2005. View at Publisher · View at Google Scholar · View at PubMed
51. D. J. MacCrimmon, J. E. Wallace, W. M. Goldberg, and D. L. Streiner, “Emotional disturbance and cognitive deficits in hyperthyroidism,” Psychosomatic Medicine, vol. 41, no. 4, pp. 331–340, 1979.
52. M. A. Alvarez, A. Gomez, E. Alavez, and D. Navarro, “Attention disturbance in Graves' disease,” Psychoneuroendocrinology, vol. 8, no. 4, pp. 451–454, 1983. View at Publisher · View at Google Scholar
53. P. T. Trzepacz, M. McCue, I. Klein, J. Greenhouse, and G. S. Levey, “Psychiatric and neuropsychological response to propanolol in Graves' disease,” Biological Psychiatry, vol. 23, no. 7, pp. 678–688, 1988. View at Publisher · View at Google Scholar
54. A. D. Toft, “Subclinical hyperthyroidism,” The New England Journal of Medicine, vol. 345, no. 7, pp. 512–516, 2001. View at Publisher · View at Google Scholar
55. J. Zeitlhofer, B. Saletu, J. Stary, and R. Ahmadi, “Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy,” Neuropsychobiology, vol. 11, no. 2, pp. 89–93, 1984. View at Publisher · View at Google Scholar
56. N. Kathman, U. Kuisle, M. Bommer, D. Naber, O.-A. Müller, and R. R. Engel, “Effects of elevated triiodothyronine on cognitive performance and mood in healthy subjects,” Neuropsychobiology, vol. 29, no. 3, pp. 136–142, 1994. View at Publisher · View at Google Scholar
57. D. M. Erlanger, K. C. Kutner, and A. R. Jacobs, “Hormones and cognition: current concepts and issues in neuropsychology,” Neuropsychology Review, vol. 9, no. 4, pp. 175–207, 1999. View at Publisher · View at Google Scholar
58. T. F. Münte, C. Radamm, S. Johannes, and G. Brabant, “Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: a double-blind cross-over study using event-related brain potentials,” Thyroid, vol. 11, no. 4, pp. 385–391, 2001. View at Publisher · View at Google Scholar · View at PubMed
59. C. Baethge, F. M. Reischies, A. Berghöfer, et al., “Effects of supraphysiological doses of L-thyroxine on cognitive function in healthy individuals,” Psychiatry Research, vol. 110, no. 2, pp. 117–123, 2002. View at Publisher · View at Google Scholar
60. M. Hayashi and A. J. Patel, “An interaction between thyroid hormone and nerve growth factor in the regulation of choline acetyltransferase activity in neuronal cultures, derived from the septal-diagonal band region of the embryonic rat brain,” Brain Research, vol. 433, no. 1, pp. 109–120, 1987.
61. D. R. Thomas, R. Hailwood, B. Harris, P. A. Williams, M. F. Scanlon, and R. John, “Thyroid status in senile dementia of the Alzheimer type (SDAT),” Acta Psychiatrica Scandinavica, vol. 76, no. 2, pp. 158–163, 1987. View at Publisher · View at Google Scholar
62. M. M. B. Breteler, C. M. van Duijn, V. Chandra, et al., “Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies,” International Journal of Epidemiology, vol. 20, pp. S36–S42, 1991.
63. D. L. Ewins, M. N. Rossor, J. Butler, P. K. Roques, M. J. Mullan, and A. M. McGregor, “Association between autoimmune thyroid disease and familial Alzheimer's disease,” Clinical Endocrinology, vol. 35, no. 1, pp. 93–96, 1991. View at Publisher · View at Google Scholar
64. R. A. Stern and A. J. Prange, Jr., “Neuropsychiatric aspects of endocrine disorders,” in Comprehensive Textbook of Psychiatry. Vol. 6, H. Kaplan and B. J. Sadock, Eds., pp. 241–251, Williams and Wilkins, Baltimore, Md, USA, 1995.
65. M. Ganguli, L. A. Burmeister, E. C. Seaberg, S. Belle, and S. T. DeKosky, “Association between dementia and elevated TSH: a community-based study,” Biological Psychiatry, vol. 40, no. 8, pp. 714–725, 1996. View at Publisher · View at Google Scholar
66. G. Genovesi, P. Paolint, L. Marcellini, et al., “Relationship between autoimmune thyroid disease Rand Alzheimer's disease,” Panminerva Medica, vol. 38, no. 1, pp. 61–63, 1996.
67. J.-M. Serot, D. Christmann, T. Dubost, and M. Couturier, “Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 63, no. 4, pp. 506–508, 1997.
68. M. J. Latasa, B. Belandia, and A. Pascual, “Thyroid hormones regulate $\beta$-amyloid gene splicing and protein secretion in neuroblastoma cells,” Endocrinology, vol. 139, no. 6, pp. 2692–2698, 1998. View at Publisher · View at Google Scholar
69. L. Luo, N. Yano, Q. Mao, I. M. D. Jackson, and E. G. Stopa, “Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients,” Journal of Alzheimer's Disease, vol. 4, no. 2, pp. 97–103, 2002.
70. A. Merched, J.-M. Serot, S. Visvikis, D. Aguillon, G. Faure, and G. Siest, “Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry,” FEBS Letters, vol. 425, no. 2, pp. 225–228, 1998. View at Publisher · View at Google Scholar
71. T. J. M. Van der Cammen, F. M. Raso, M.-C. de Jager, and F. van Harskamp, “Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population,” Journal of the American Geriatrics Society, vol. 51, no. 6, p. 884, 2003. View at Publisher · View at Google Scholar
72. F. J. de Jong, K. Masaki, H. Chen, et al., “Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia Aging Study,” Neurobiol Aging, 2007. View at Publisher · View at Google Scholar · View at PubMed
73. L. A. D. M. van Osch, E. Hogervorst, M. Combrinck, and A. D. Smith, “Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease,” Neurology, vol. 62, no. 11, pp. 1967–1971, 2004.
74. S. Kalmijn, K. M. Mehta, H. A. P. Pols, A. Hofman, H. A. Drexhage, and M. M. B. Breteler, “Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study,” Clinical Endocrinology, vol. 53, no. 6, pp. 733–737, 2000. View at Publisher · View at Google Scholar
75. O. Lopez, F. J. Huff, A. J. Martinez, and C. D. Bedetti, “Prevalence of thyroid abnormalities is not increased in Alzheimer's disease,” Neurobiology of Aging, vol. 10, no. 3, pp. 247–251, 1989. View at Publisher · View at Google Scholar
76. G. W. Small, S. S. Matsuyama, R. Komanduri, V. Kumar, and L. F. Jarvik, “Thyroid disease in patients with dementia of the Alzheimer type,” Journal of the American Geriatrics Society, vol. 33, no. 8, pp. 538–539, 1985.
77. S. Annerbo, L.-O. Wahlund, and J. Lökk, “The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment. A 6-year follow-up study,” American Journal of Alzheimer's Disease and other Dementias, vol. 21, no. 3, pp. 182–188, 2006. View at Publisher · View at Google Scholar
78. R. A. Stern, J. D. Davis, B. L. Rogers, et al., “Preliminary study of the relationship between thyroid status and cognitive and neuropsychiatric functioning in euthyroid patients with Alzheimer dementia,” Cognitive and Behavioral Neurology, vol. 17, no. 4, pp. 219–223, 2004.
79. P. T. Loosen, “Effects of thyroid hormones on central nervous system in aging,” Psychoneuroendocrinology, vol. 17, no. 4, pp. 355–374, 1992. View at Publisher · View at Google Scholar
80. J. Robbins, “Thyroid hormone transport proteins and the physiology of hormone binding,” in The Thyroid: A Fundamental and Clinical Text, L. E. Braverman and R. D. Utiger, Eds., pp. 96–110, Lippincott-Raven, Philadelphia, Pa, USA, 2000.
81. M. B. Dratman, F. L. Crutchfield, J. T. Gordon, and A. S. Jennings, “Iodothyronine homeostasis in rat brain during hypo- and hyperthyroidism,” The American Journal of Physiology, vol. 245, no. 2, pp. E185–E193, 1983.
82. S. Mariotti, “Thyroid function and aging: do serum 3,5,$3^{\prime }$- triiodothyronine and thyroid-stimulating hormone concentrations give the Janus response?,” Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 12, pp. 6735–6737, 2005. View at Publisher · View at Google Scholar · View at PubMed
83. A. W. van den Beld, T. J. Visser, R. A. Feelders, D. E. Grobbee, and S. W. J. Lamberts, “Thyroid hormone concentrations, disease, physical function, and mortality in elderly men,” Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 12, pp. 6403–6409, 2005. View at Publisher · View at Google Scholar · View at PubMed
84. G. S. Meneilly, “Should subclinical hypothyroidism in elderly patients be treated?,” Canadian Medical Association Journal, vol. 172, no. 5, p. 633, 2005. View at Publisher · View at Google Scholar · View at PubMed
85. R. P. Peeters, Y. Debaveye, E. Fliers, and T. J. Visser, “Changes within the thyroid axis during critical illness,” Critical Care Clinics, vol. 22, no. 1, pp. 41–55, 2006. View at Publisher · View at Google Scholar · View at PubMed
86. G. A. C. van Haasteren, E. Linkels, H. van Toor, et al., “Effects of long-term food reduction on the hypothalamus-pituitary-thyroid axis in male and female rats,” Journal of Endocrinology, vol. 150, no. 2, pp. 169–178, 1996. View at Publisher · View at Google Scholar
87. H. Gharib, R. M. Tuttle, H. J. Baskin, L. H. Fish, P. A. Singer, and M. T. McDermott, “Consensus statement: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society,” Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 1, pp. 581–585, 2005. View at Publisher · View at Google Scholar · View at PubMed
88. S. Myers Adler and K. D. Burman, “Abnormalities in thyroid function parameters and subclinical thyroid disease in the elderly: a brief review,” Hot Thyroidology, no. 1, July 2007.
89. Y. Krausz, N. Freedman, H. Lester, et al., “Regional cerebral blood flow in patients with mild hypothyroidism,” Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1712–1715, 2004.
90. E. L. Constant, A. G. de Volder, A. Ivanoiu, et al., “Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study,” Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 8, pp. 3864–3870, 2001. View at Publisher · View at Google Scholar